$5.3T
CMS says U.S. health spending grew 7.2 percent in 2024 and reached 18.0 percent of GDP.
Healthcare belongs on this site because pricing power, opaque ownership, and influence markets shape care access as reliably as medical need does. This page starts with live official benchmarks and then follows the ownership, billing, and lobbying records behind them.
CMS says U.S. health spending grew 7.2 percent in 2024 and reached 18.0 percent of GDP.
Official CMS 2024 per-person spending estimate from the National Health Expenditure Accounts.
CMS says Program Year 2024 Open Payments data includes 16.16 million published records totaling $13.18 billion.
These are the healthcare indicators we can state directly right now using current official records. They do not settle every policy argument, but they do anchor the scale of the system we are describing.
CMS says U.S. health spending grew 7.2 percent in 2024 and reached 18.0 percent of GDP.
Official CMS 2024 per-person spending estimate from the National Health Expenditure Accounts.
CMS says private health insurance spending reached $1.6446 trillion in 2024.
CMS says Program Year 2024 Open Payments data includes 16.16 million published records totaling $13.18 billion.
This page is not here to posture about a broken system. These are the reporting paths that turn scattered grievances into document-first healthcare stories.
Hospitals, insurers, pharmacy benefit managers, and drug makers all leave public records behind. The reporting job is to connect pricing, ownership, reimbursement, and lobbying into one timeline instead of treating each cost spike as isolated.
A denial loop is a utilization, coding, and reimbursement story that can be checked against payer filings, CMS datasets, enforcement actions, and audit reports.
When employers anchor access to insurance, care costs do not stay inside the health system. They spill into wages, housing stability, household debt, and labor leverage across the rest of the economy.
Official annual spending totals, payer mix, and per-person spending.
Financial disclosures covering payments and ownership interests reported by drug and device companies.
Provider, ownership, utilization, and billing datasets for hospitals, clinicians, and insurers.
Audits, enforcement actions, and investigations involving federal healthcare programs.
Public-company filings for insurers, hospital systems, pharmacy benefit managers, and drug manufacturers.
No pricing or denial claim publishes as a quantified public finding until a visible source stack is attached on the page.
Anecdotes can guide reporting, but recurring system claims need federal data, filings, or enforcement records behind them.
Cross-system claims stay framed as review work until the health, labor, and housing records all point in the same direction.

The pandemic-era affordability boost expired, 2026 subsidy math got harsher, and families already under cost pressure took the hit.

Statistics Canada, Health Canada, and CIHI put numbers on the same workforce problem: internationally trained health workers are underused while millions of Canadians still lack regular care.

The current federal record already gives the outline of the story: $15,474 per person, $1.64 trillion through private insurance, and $13.18 billion in disclosed industry transfers and ownership interests. The harder question is how much of that system is paying for care and how much is paying for power.